ChemicalBook
Chinese English Germany Korean

Wuhan Jingkangen Biomedical Technology Co., Ltd 企業の連絡先情報

名前:Wuhan Jingkangen Biomedical Technology Co., Ltd
電話番号:00-13720134139 +86 -0-15871494362
電子メール:orders@jknbiochem.com
国籍:China
ウェブサイト:www.jknbiochem.com
商品の合計数:4958
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50

製品カタログ

FigitumumabCP-751871943453-46-1
Exbivirumab569658-80-6
Raxibacumab565451-13-0
Tefibazumab521079-87-8
Elsilimomab468715-71-1
Pritumumab499212-74-7
Urtoxazumab502496-16-4
Belimumabベリムマブ（遺伝子組換え）356547-88-1
Libivirumab569658-79-3
Vapaliximab336801-86-6
Teneliximab395639-53-9
reslizumab241473-69-8
Ecromeximab292819-64-8
Research Grade Anatumomab
CixutumumabIMC-A12947687-12-9
Elotuzumabエロツズマブ（遺伝子組換え)915296-00-3
Farletuzumaファルレツズマブ（遺伝子組換え）896723-44-7
Research Grade Pintumomab
Research Grade Sibrotuzumab
Lemalesomab250242-54-7
Research Grade Bivatuzumab
Research Grade Taplitumomab
Erlizumab211323-03-4
Epitumomab372075-37-1
Denosumabデノスマブ（遺伝子組換え）615258-40-7C6404H9912N1724O2004S50
Iratumumab640735-09-7
Tremelimumabトレメリムマブ（遺伝子組換え）745013-59-6
Alacizumab934216-54-3
Dacetuzumab880486-59-9
Anrukinzumab910649-32-0
Tigatuzumabチガツズマブ918127-53-4
Otelixizumab881191-44-2
Oportuzumab Monatox945228-48-8
Etaracizumab892553-42-3
Citatuzumab Bogatox945228-49-9
Obinutuzumabオビヌツズマブ（遺伝子組換え）949142-50-1
Panobacumab885053-97-4
Ibalizumab680188-33-4
Canakinumabカナキヌマブ（遺伝子組換え）914613-48-2
Enobosarm/MK2866エノボサーム841205-47-8C19H14F3N3O3
Bavituximab648904-28-3
Cetuximabセツキシマブ（遺伝子組換え）205923-56-4C107H179N35O36S7
Acadesineアカデシン2627-69-2C9H14N4O5
Cardarine/GW501516GW501516317318-70-0C21H18F3NO3S2
Maribavirマリバビル176161-24-3C15H19Cl2N3O4
LGD40331165910-22-4C14H12F6N2O
Racotumomab946832-34-4
Pagibaximab595566-61-3
Bapineuzumabバピノイズマブ648895-38-9
ocrelizumabオクレリズマブ（遺伝子組換え）637334-45-3C19H16N2O5
Research Grade Camidanlumab921618-45-3
Tenatumomab1412891-40-7
Tanezumabタネズマブ（遺伝子組換え）880266-57-9
Yttrium (90Y) Tacatuzumab Tetraxetan476413-07-7
Tucotuzumab Celmoleukin339986-90-2
Besilesomab537694-98-7
notuzumabイノツズマブ　オゾガマイシン（遺伝子組換え）635715-01-4
Volociximab558480-40-3
Lumiliximab357613-86-6
Research Grade Priliximab147191-91-1
Briakinumab339308-60-0
Adecatumumab503605-66-1
Infliximabインフリキシマブ（遺伝子組換え）［インフリキシマブ後続２］170277-31-3
Keliximab174722-30-6
Research Grade Clenoliximab182912-58-9
Galiximabガリキシマブ357613-77-5
Tuvirumab138660-97-6
Ganitumab905703-97-1
Catumaxomab509077-98-9
Gantenerumabガンテネルマブ（遺伝子組換え）1043556-46-2
Conatumumab896731-82-1
Ertumaxomab509077-99-0
Metelimumab272780-74-2
Stamulumab705287-60-1
Research Grade Otilimabオチリマブ（遺伝子組換え）1638332-55-4
Nebacumab138661-01-5
Lexatumumabレキサツムマブ845816-02-6
Research Grade HuCC49823788-82-5
Mapatumumab658052-09-6
Panitumumabパニツムマブ（遺伝子組換え）339177-26-3
ofatumumabオファツムマブ（遺伝子組換え）679818-59-8
Regavirumabレガビルマブ153101-26-9
Zanolimumabザノリムマブ652153-01-0
Zalutumumab667901-13-5
Research Grade Golimumabゴリムマブ（遺伝子組換え）476181-74-5
Ipilimumabイピリムマブ（遺伝子組換え）477202-00-9
Fresolimumab948564-73-6
Ustekinumabウステキヌマブ（遺伝子組換え）815610-63-0
Efungumab762260-74-2
Tralokinumabトラロキヌマブ（遺伝子組換え）1044515-88-9
Bertilimumab375348-49-5
Research Grade J695
Research Grade Lerdelimumab285985-06-0
SU540815966-93-5C18H18N2O3
Vosilasarm/RAD1402-クロロ-4-[[(1R,2S)-1-[5-(4-シアノフェニル)-1,3,4-オキサジアゾール-2-イル]-2-ヒドロキシプロピル]アミノ]-3-メチルベンゾニトリル1182367-47-0C20H16ClN5O2
Andarine/S-4アンダリン401900-40-1C19H18F3N3O6
Ibutamoren mesylate/MK677イブタモレンメシル酸塩159752-10-0C28H40N4O8S2
SR90093-[[(4-クロロベンジル)(5-ニトロチオフェン-2-イルメチル)アミノ]メチル]ピロリジン-1-カルボン酸エチル1379686-30-2C20H24ClN3O4S
LGD3033917891-35-1C16H14ClF3N2O
YK11YK11431579-34-9C25H34O6
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Copyright 2017 © ChemicalBook. All rights reserved